These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Re: Immediate versus deferred treatment for advanced prostate cancer: initial results of the medical research council trial. Kirk D J Urol; 1998 Jun; 159(6):2105-6. PubMed ID: 9598549 [No Abstract] [Full Text] [Related]
71. Clinical perspectives on preclinical models of bone pain: questions and promises. Portenoy R Pain; 2011 Nov; 152(11):2455-2456. PubMed ID: 21868166 [No Abstract] [Full Text] [Related]
72. Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study. Clarke NW; Holbrook IB; McClure J; George NJ Br J Cancer; 1991 Mar; 63(3):420-3. PubMed ID: 2003984 [TBL] [Abstract][Full Text] [Related]
73. Manifestations of advanced prostate cancer: prognosis and treatment. Surya BV; Provet JA J Urol; 1989 Oct; 142(4):921-8. PubMed ID: 2677414 [No Abstract] [Full Text] [Related]
74. Disseminated intravascular coagulation complicating Ender's nailing of a pathologic fracture in prostatic carcinoma. A case report. Olson SA; Humphreys WG; Allen WC Clin Orthop Relat Res; 1990 Sep; (258):242-4. PubMed ID: 2394052 [TBL] [Abstract][Full Text] [Related]
75. Management of pain and other symptoms of advanced prostatic cancer. Labasky RF; Smith JA Semin Urol; 1988 Nov; 6(4):311-21. PubMed ID: 3068769 [No Abstract] [Full Text] [Related]
76. Quality of life of patients with advanced and metastatic prostatic carcinoma. Villavicencio H Eur Urol; 1993; 24 Suppl 2():118-21. PubMed ID: 8262116 [TBL] [Abstract][Full Text] [Related]